MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-11-06: Reporting owner KRAEUTLER JOHN A; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-11-05: Reporting owner ROLIH SUSAN; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-11-05: Reporting owner LUEKE MELISSA; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-08-14: Reporting owner McIlwraith John; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-11-06 | KRAEUTLER JOHN A Director, Officer (Chairman and CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $14.01 exercise price | 2015-11-10 | |
| 2015-11-05 | ROLIH SUSAN Officer (EVP, Reg & Quality Systems) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $14.01 exercise price | 2015-11-10 | |
| 2015-11-05 | LUEKE MELISSA Officer (Exec VP, CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $14.01 exercise price | 2015-11-10 | |
| 2015-08-14 | McIlwraith John Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $18.18 exercise price | 2015-08-18 | |
| 2015-08-14 | Sazdanoff Catherine Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $18.18 exercise price | 2015-08-18 | |
| 2015-01-22 | PHILLIPS DAVID Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $17.34 exercise price | 2015-01-23 | |
| 2015-01-22 | READY ROBERT J Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $17.34 exercise price | 2015-01-23 | |
| 2015-01-22 | Ellingwood Dwight E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $17.34 exercise price | 2015-01-23 | |
| 2015-01-22 | Anderson James M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $17.34 exercise price | 2015-01-23 | |
| 2015-01-15 | KRAEUTLER JOHN A Director, Officer (Chairman and CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $16.50 exercise price | 2015-01-20 | |
| 2015-01-15 | KRAEUTLER JOHN A Director, Officer (Chairman and CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $16.50 exercise price | 2015-01-20 | |
| 2015-01-09 | READY ROBERT J Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,214 0 owned after | $7.05 exercise price | 2015-01-13 |